Not a good buy right now for an impatient trader: no Intellectia buy signals, bearish-to-neutral technicals, and modelled next-week/next-month drift is negative.
Best stance is HOLD/AVOID new entries until price proves strength (reclaiming ~$13.27 pivot and pushing toward $14.06 resistance) or a new proprietary signal appears.
Trend/momentum: MACD histogram at -0.183 (below zero) and only “negatively contracting” → bearish momentum still present, not a clear reversal.
RSI(6) ~43.9 → neutral-to-soft; not oversold, so no strong mean-reversion “buy-the-dip” edge.
Moving averages are converging → consolidation/chop; typically needs a breakout to confirm direction.
Key levels: Pivot ~$13.274 (price ~$13.26 is just below it). Support: $12.49 then $12.00. Resistance: $14.06 then $14.55.
Pattern-based expectation: similar candlestick set implies ~60% odds of mild downside (-1.57% next week; -1.55% next month) → unfavorable for immediate entry.
Positive Catalysts
Gross margin improved significantly (reported +73.49% YoY to 18.06), which could support future earnings quality if sustained.
Upcoming earnings: 2026-02-12 (After Hours) can act as a volatility catalyst if results surprise positively.
Hedge funds/insiders show neutral activity (no notable selling pressure indicated by provided trends).
Neutral/Negative Catalysts
with already-weak profit trend going into the print.
Financial Performance
Latest quarter: 2025/Q3.
Revenue: $7.36M, +5.60% YoY (top-line growth is modestly positive).
Net income: $67.6K, down ~104.67% YoY (profitability collapsed vs prior year comparison).
EPS: $0.07, down ~104.67% YoY.
Gross margin: 18.06, up 73.49% YoY (a bright spot, but not yet translating into stronger bottom-line results).
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating / price target change data provided (and micro-cap names like CVR often have limited or no active Wall Street coverage).
Wall Street pro/con view cannot be meaningfully confirmed from the dataset; absent coverage typically reduces near-term sentiment catalysts and leaves price driven more by liquidity, earnings, and technicals.
Wall Street analysts forecast CVR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CVR is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast CVR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CVR is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
